Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases

被引:81
作者
Ramasubbu, R [1 ]
机构
[1] Univ Calgary, Foothills Hosp, Dept Psychiat, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.1016/S0306-9877(02)00244-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The association of depression with insulin resistance (IR) and athersclerotic vascular diseases has been well documented. This review examines the relevance of IR as a link between depressive disorder and atherosclerotic vascular diseases. Relevant articles collected from Medline database over the period of 19662001 were reviewed. Studies have shown that IR is a state-dependent abnormality in depression and depression increases the risk of vascular morbidity and mortality. Given that IR is a central component of cardiovascular risk factors, depression-related IR might play a role in the development and progression of coronary and cerebral atherosclerosis in chronic-resistant depression. Further, IR may contribute to the pathophysiology of depressive disorder. In conclusion IR could account for the linkage between depression and atherosclerotic vascular diseases. More studies are needed to examine the importance of improving insulin sensitivity in the treatment of chronic-resistant depression and prevention of depression-related vascular morbidity and mortality (15). (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:537 / 551
页数:15
相关论文
共 153 条
[1]
INHIBITION OF INSULIN RELEASE BY SUBSTRATES AND INHIBITORS OF MONOAMINE-OXIDASE [J].
ALEYASSINE, H ;
LEE, SH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1972, 222 (03) :565-+
[2]
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder [J].
Alpert, JE ;
Fava, M ;
Uebelacker, LA ;
Nierenberg, AA ;
Pava, JA ;
Worthington, JJ ;
Rosenbaum, JF .
BIOLOGICAL PSYCHIATRY, 1999, 46 (02) :202-211
[3]
DEPRESSED AFFECT, HOPELESSNESS, AND THE RISK OF ISCHEMIC-HEART-DISEASE IN A COHORT OF UNITED-STATES ADULTS [J].
ANDA, R ;
WILLIAMSON, D ;
JONES, D ;
MACERA, C ;
EAKER, E ;
GLASSMAN, A ;
MARKS, J .
EPIDEMIOLOGY, 1993, 4 (04) :285-293
[4]
Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
[5]
Role of catecholamines in platelet function: Pathophysiological and clinical significance [J].
Anfossi, G ;
Trovati, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (05) :353-370
[6]
Arato M, 1986, Ann N Y Acad Sci, V487, P263, DOI 10.1111/j.1749-6632.1986.tb27905.x
[7]
Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months [J].
Babyak, M ;
Blumenthal, JA ;
Herman, S ;
Khatri, P ;
Doraiswamy, M ;
Moore, K ;
Craighead, E ;
Baldewicz, TT ;
Krishnan, KR .
PSYCHOSOMATIC MEDICINE, 2000, 62 (05) :633-638
[8]
Banki C M, 1992, Eur Neuropsychopharmacol, V2, P107, DOI 10.1016/0924-977X(92)90019-5
[9]
BANKI CM, 1987, AM J PSYCHIAT, V144, P873
[10]
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample [J].
Barefoot, JC ;
Schroll, M .
CIRCULATION, 1996, 93 (11) :1976-1980